Since 2002, Dana-Farber has sent its Mammography Van around Boston to provide breast cancer screenings to women who otherwise wouldn’t get checked. Dana-Farber uses data from patient surveys to determine exactly where the mobile unit’s services are needed.
Dr. Anne Partridge commented on a study that found double mastectomies do not improve the chances of survival for women at average risk of breast cancer recurrence.
Dr. Eric Winer commented on a blood test that could reduce the number of women who need chemotherapy after tumor removal surgery.
Rosenberg, ScD, led a survey that found women who have double mastectomies
generally overestimate their likelihood of getting cancer in the healthy
Dr. Judy Garber comments on Dana-Farber researchers using healthy breast tissue from high-risk patients to prevent breast cancer.
Rachel Freedman commented on targeted treatments – those that attack a specific
characteristic of a cancer strain – becoming the norm in breast cancer care.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: